Publicaciones (15) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. Acral peeling skin syndrome resulting from mutations in TGM5

    Journal of the European Academy of Dermatology and Venereology

  2. Asistencia ventricular con oxigenador extracorpóreo de membrana: un arma de doble filo. Respuesta

    Revista Espanola de Cardiologia

  3. Comment on 'Wild-type APC prediction of poor prognosis in microsatellite-stable proximal colorectal cancer differs according to the age of onset'

    British Journal of Cancer

  4. Competencias profesionales y trabajo en equipo en pacientes con enfermedades cardiacas agudas y críticas. Respuesta

    Revista Espanola de Cardiologia

  5. Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia

    Leukemia

  6. Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos

    Revista de Psiquiatria y Salud Mental

  7. Data from acellular human heart matrix

    Data in Brief

  8. Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion

    British Journal of Haematology

  9. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  10. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

    Haematologica

  11. GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: Results of a multicenter study

    Bone Marrow Transplantation

  12. Molecular control of non-muscle myosin II assembly

    Oncotarget

  13. Nutrients control cell size

    Cell Cycle

  14. Proximity of AUG sequences to initiation codon in genomic 5′ UTR regulates mammalian protein expression

    Gene

  15. The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: A pilot trial from the GETH and GELLC (CLL4 trial)

    Bone Marrow Transplantation